Heart failure (HF) is an extremely relevant chronic disease impacting on quality of life and prognosis. Furthermore, the increasing prevalence of HF leads to a huge number of admissions and entails an important use of resources and healthcare costs [1]. For these reasons, the optimization of its management is crucial, including early diagnosis, pharmacological treatment, cardiac devices, HF community programmes, etc.
